Español
India
Italiano
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
CryoPort
(NASDAQ:CYRX)
Intraday
$11.11
0
[0.00%]
After-Hours
$11.11
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$11.11
0
[0.00%]
At close: Jun 6
$11.11
0
[0.00%]
After Hours: 4:00PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for CryoPort Stock (NASDAQ:CYRX)
CryoPort Stock (NASDAQ: CYRX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, May 08, 2024
CryoPort shares are trading lower after the company reported worse-than-expected Q1 financial results.
Benzinga Newsdesk
Needham Reiterates Buy on CryoPort, Maintains $18 Price Target
Benzinga Newsdesk
Tuesday, May 07, 2024
CryoPort Reiterates FY24 Revenue $242M-$252M Vs $245.600M Est.
Benzinga Newsdesk
CryoPort Q1 2024 GAAP EPS $(0.43) Misses $(0.35) Estimate, Sales $54.592M Miss $58.760M Estimate
Benzinga Newsdesk
Friday, May 03, 2024
Coinbase Global To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Friday
Avi Kapoor
Stem Reports Downbeat Results, Joins Sprout Social, Cloudflare And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Avi Kapoor
Analyst Ratings For CryoPort
Benzinga Insights
B. Riley Securities Downgrades CryoPort to Neutral, Lowers Price Target to $19
Benzinga Newsdesk
Thursday, April 04, 2024
Assessing CryoPort: Insights From 5 Financial Analysts
Benzinga Insights
Jefferies Assumes CryoPort at Buy, Raises Price Target to $21
Benzinga Newsdesk
Friday, March 15, 2024
Analyst Ratings For CryoPort
Benzinga Insights
UBS Maintains Neutral on CryoPort, Raises Price Target to $17
Benzinga Newsdesk
Thursday, March 14, 2024
Build-A-Bear Workshop Reports Upbeat Earnings, Joins VAALCO Energy, Dick's Sporting Goods And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Wednesday, March 13, 2024
Stephens & Co. Reiterates Equal-Weight on CryoPort, Maintains $17 Price Target
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
CryoPort shares are trading lower after the company reported worse-than-expected Q4 financial results and issued FY24 revenue guidance below estimates.
Benzinga Newsdesk
Needham Maintains Buy on CryoPort, Lowers Price Target to $18
Benzinga Newsdesk
Tuesday, March 12, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Recap: CryoPort Q4 Earnings
Benzinga Insights
CryoPort Sees FY24 Revenue $242M-$252M vs $253.22M Est.
Benzinga Newsdesk
CryoPort Q4 2023 GAAP EPS $(1.31) Misses $(0.30) Estimate, Sales $57.260M Miss $58.396M Estimate
Benzinga Newsdesk
Earnings Scheduled For March 12, 2024
Benzinga Insights
Monday, March 11, 2024
Earnings Preview: CryoPort
Benzinga Insights
Thursday, January 18, 2024
Needham Maintains Buy on CryoPort, Raises Price Target to $19
Benzinga Newsdesk
Monday, November 27, 2023
Cryoport And NIPPON EXPRESS HOLDINGS Form Global Strategic Partnership For Temperature-Controlled Supply Chain Services
Benzinga Newsdesk
Thursday, November 16, 2023
CryoPort's CRYOPDP Expands U.S. Footprint With Acquisition Of Bluebird Express; Terms Not Disclosed
Benzinga Newsdesk
Wednesday, November 08, 2023
CryoPort Q3 EPS $(0.31), Inline, Sales $56.16M Beat $55.27M Estimate
Benzinga Newsdesk
Earnings Scheduled For November 8, 2023
Benzinga Insights
Thursday, October 12, 2023
Cryoport Inks New Multi-Year Supply Chain Solutions Agreement With Monash IVF
Benzinga Newsdesk
Tuesday, October 10, 2023
Cryoport And Cell And Gene Therapy Catapult Announce Strategic Collaboration At Stevenage Manufacturing Innovation Centre For Advancement Of Cell And Gene Therapies
Benzinga Newsdesk
Monday, October 09, 2023
Be The Match BioTherapies And Cryoport Partner To Accelerate The Development Of Cell And Gene Therapies
Benzinga Newsdesk
Thursday, September 14, 2023
CryoPort Chief Scientific Officer Acquires 1,000 Shares After Exercising Company Stock Options
Benzinga Insights
Monday, September 11, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Thursday, August 17, 2023
Benzinga's Top Ratings Upgrades, Downgrades For August 17, 2023
Benzinga Insights
Morgan Stanley Initiates Coverage On CryoPort with Equal-Weight Rating, Announces Price Target of $16
Benzinga Newsdesk
Thursday, August 10, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
9 Analysts Have This to Say About CryoPort
Benzinga Insights
Needham Maintains Buy on CryoPort, Lowers Price Target to $21
Benzinga Newsdesk
Wednesday, August 09, 2023
CryoPort Sees FY23 Revenue $233M-$243M Vs $243.24M Est
Benzinga Newsdesk
CryoPort Q2 EPS $(0.42) Misses $(0.24) Estimate, Sales $57.02M Miss $59.36M Estimate
Benzinga Newsdesk
Earnings Scheduled For August 9, 2023
Benzinga Insights
Tuesday, August 08, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, August 07, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Tuesday, July 18, 2023
Benzinga's Top Ratings Upgrades, Downgrades For July 18, 2023
Benzinga Insights
UBS Downgrades CryoPort to Neutral, Lowers Price Target to $17
Benzinga Newsdesk
Monday, July 17, 2023
CryoPort's Refrigeration Unit Is A Distraction From Core Business: Analyst Expects Divestiture
Nabaparna Bhattacharya
Benzinga's Top Ratings Upgrades, Downgrades For July 17, 2023
Benzinga Insights
Stephens & Co. Downgrades CryoPort to Equal-Weight, Lowers Price Target to $15
Benzinga Newsdesk
Expert Ratings for CryoPort
Benzinga Insights
Keybanc Downgrades CryoPort to Sector Weight
Benzinga Newsdesk
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch